- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04400461
Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation
Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation: an Observational Cohort Study
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
DESIGN: An observation cohort study conducted in a tertiary hospital.
METHODS: Data will be collected from patients along the ICU-hospital discharge continuum, will be analysed and non-parametric tests will be used to explore association between variables.
Outcome measures: Muscle strength, as a component of physical function, will be evaluated with the Medical Research Council sum score (MRC- SS) at discharge from ICU and at hospital discharge; the Functional Status Score for the ICU (FSS-ICU) will also be assessed at hospital discharge. Data on participants' demographics, ICU admission and hospital admission will also be collected.
SIGNIFICANCE OF THE RESEARCH: Understanding how physical function is affected in patients with severe COVID-19 may help develop future prevention, therapeutic and follow-up strategies that improve quality of care and outcomes in this specific group of patients. Findings from this study may be useful to design future larger cohort studies and experimental trials.
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
-
Madrid, Espanha, 28034
- Medical ICU. Hospital Universitario Ramón y Cajal
-
Madrid, Espanha, 28034
- Surgical ICU. Hospital Universitario Ramón y Cajal
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- subjects diagnosed with COVID-19 who have required admission to ICU for invasive mechanical ventilation;
- have received invasive ventilation > 24 hours;
- have been successfully weaned from mechanical ventilation > 48 hours;
- were independently able to mobilise prior to current hospital admission (this includes subjects who used a walking stick or another gait aid to mobilise.
Exclusion Criteria:
- subjects or proxies with inability to communicate in Spanish fluently;
- cognitive impairment prior to ICU admission;
- proven neurological impairment or neuromuscular disorder;
- Cerebrovascular Accident during hospital stay;
- previous organ transplant;
- pregnancy;
- unstable fractures or any other injuries that would require medical bed rest.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Medical Research Council sum score (MRC- SS).
Prazo: < 48 hours before ICU discharge
|
Physical examination will be performed to carry out manual muscle testing of strength in 6 different muscle groups of the upper limb and lower limb on both sides of the body.
|
< 48 hours before ICU discharge
|
Medical Research Council sum score (MRC- SS).
Prazo: < 24 hours before hospital discharge
|
Physical examination will be performed to carry out manual muscle testing of strength in 6 different muscle groups of the upper limb and lower limb on both sides of the body.
|
< 24 hours before hospital discharge
|
The Functional Status Score for the ICU (FSS-ICU)
Prazo: < 24 hours before hospital discharge
|
The Functional Status Score for the ICU (FSS-ICU) will be used to evaluate 5 functional tasks.
Each task is evaluated using an 8-point ordinal scale ranging from 0 (not able to perform) to 7 (complete independence).The total FSS-ICU score ranges from 0 to 35, with higher scores indicating better physical functioning.
|
< 24 hours before hospital discharge
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Age
Prazo: Through study completion, up to 6 months
|
Age in years
|
Through study completion, up to 6 months
|
Sex
Prazo: Throughout study completion , up to 6 month
|
Male vs Female
|
Throughout study completion , up to 6 month
|
Body Mass Index
Prazo: Throughout study completion, up to 6 months
|
kg/m2
|
Throughout study completion, up to 6 months
|
Baseline mobility
Prazo: First day the patient can cooperate with assessment according to the ' 5 Standard Questions' test.
|
Baseline mobility
|
First day the patient can cooperate with assessment according to the ' 5 Standard Questions' test.
|
APACHE II score
Prazo: <24 hours after ICU admission
|
Acute Physiology and Chronic Health Evaluation II score.The APACHE II score ranges from 0 to 71 points.
Higher scores correspond to more severe disease and a higher risk of death.
|
<24 hours after ICU admission
|
Length of stay in ICU
Prazo: Throughout the study completion, up to 6 months
|
Number of days of stay in ICU
|
Throughout the study completion, up to 6 months
|
Number of days on mechanical ventilation
Prazo: Throughout the study completion, up to 6 months
|
Number of days on mechanical ventilation
|
Throughout the study completion, up to 6 months
|
Polyneuropathy diagnosis
Prazo: Throughout the study completion, up to 6 months
|
Clinical or EMG polyneuropathy diagnosis confirmation
|
Throughout the study completion, up to 6 months
|
Number of days on Neuromuscular Blockers
Prazo: Throughout the study completion, up to 6 months
|
Number of days on NMB during mechanical ventilation
|
Throughout the study completion, up to 6 months
|
Episodes of prone positioning
Prazo: Throughout the study completion, up to 6 months
|
Number of prone positioning episodes during ICU stay
|
Throughout the study completion, up to 6 months
|
Length of stay in hospital
Prazo: Throughout the study completion, up to 6 months
|
Total number of days admitted to hospital
|
Throughout the study completion, up to 6 months
|
Continuation of care
Prazo: Throughout the study completion, up to 6 months
|
Home with no follow-up physiotherapy, home with domiciliary or out-patient physiotherapy, rehabilitation facility, care home, transfer to another acute hospital.
|
Throughout the study completion, up to 6 months
|
Colaboradores e Investigadores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 165/20
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em COVID-19
-
Yang I. PachankisAtivo, não recrutandoInfecção Respiratória COVID-19 | Síndrome de Estresse COVID-19 | Reação adversa à vacina COVID-19 | Tromboembolismo associado à COVID-19 | Síndrome Pós-Cuidados Intensivos COVID-19 | AVC associado à COVID-19China
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios...ConcluídoSequelas pós-agudas de COVID-19 | Condição pós-COVID-19 | Longo-COVID | Síndrome COVID-19 CrônicaItália
-
Massachusetts General HospitalRecrutamentoSíndrome pós-aguda de COVID-19 | Longo COVID | Sequelas pós-agudas de COVID-19 | Longo COVID-19Estados Unidos
-
Erasmus Medical CenterDa Vinci Clinic; HGC RijswijkAinda não está recrutandoSíndrome pós-COVID-19 | Longo COVID | Longo Covid19 | Condição pós-COVID-19 | Síndrome pós-COVID | Condição pós-COVID-19, não especificada | Condição Pós-COVIDHolanda
-
Indonesia UniversityRecrutamentoSíndrome pós-COVID-19 | Longo COVID | Condição pós-COVID-19 | Síndrome pós-COVID | Longo COVID-19Indonésia
-
First Affiliated Hospital Xi'an Jiaotong UniversityShangluo Central Hospital; Ankang Central Hospital; Hanzhong Central Hospital; Yulin... e outros colaboradoresRecrutamentoCOVID-19 | Síndrome pós-COVID-19 | Pós-Agudo COVID-19 | COVID-19 agudoChina
-
University of Witten/HerdeckeInstitut für Rehabilitationsforschung NorderneyConcluídoSíndrome pós-COVID-19 | Síndrome de Longo-COVID-19Alemanha
-
Medisch Spectrum TwenteZiekenhuisgroep Twente; University of TwenteAtivo, não recrutando
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecrutamentoPandemia do covid-19 | Vacinas para o covid-19 | Doença do vírus COVID-19Indonésia